Optimal conditions should be determined byt he investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
Lot specific
Buffer
Supplied in liquid form with 10 mM HEPES, pH 7.4, 150 mM NaCl, 50 % (v/v) glycerol.
Handhabung
Avoid repeated freeze/thaw cycles. Product will become viscous but will not freeze. Avoid storage in frost-free freezers. Allow product to warm to room temperature and gently mix before use. Dilute only prior to immediate use.
FX antikoerper, FXA antikoerper, Cf10 antikoerper, fX antikoerper, fi12c10 antikoerper, wu:fi12c10 antikoerper, F10 antikoerper, f10 antikoerper, coagulation factor X antikoerper, Coagulation factor X antikoerper, coagulation factor 10 L homeolog antikoerper, F10 antikoerper, f10 antikoerper, CpipJ_CPIJ012712 antikoerper, CpipJ_CPIJ014863 antikoerper, CpipJ_CPIJ016937 antikoerper, CpipJ_CPIJ017791 antikoerper, fa10 antikoerper, f10.L antikoerper
Hintergrund
Factor X is a vitamin K-dependent protein zymogen which is synthesized in the liver and circulates in plasma as a two chain molecule linked by a disulfide bond. Prior to secretion into plasma, post-translational modifications produce 11 gamma-carboxyglutamic acid (gla) residues and a single b-hydroxyaspartic acid residue, which are located within the NH2-terminal light chain. The light chain also contains two epidermal growth factor (EGF) homology domains. Synonyms: Polyclonal Factor X antibody, Anti-Factor X antibody, Complement Factor X antibody.